Why test patient education materials?

European Union (EU) Guidance (Volume 9A Guidelines on Pharmacovigilance) states that “Experts in risk communication should be consulted as appropriate” when providing information associated with risk minimisation activities.

  • Luto are experts in risk communication associated with medicines usage. Professor Theo Raynor and Dr Peter Knapp have published over 10 research papers in the area of risk communication.
The same EU guidance also states: “Pre-testing materials in the target audience is highly desirable to help ensure good comprehension and acceptance of the communication method and contents. A variety of testing methods such as Readability Testing...could be used”.
  • Luto is one of the market leading organisations for Readability Testing of patient information and educational material in the EU. We have an experienced team dedicated to enhancing educational materials through the application of Readability Testing techniques.